Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics Shop Miraculins, University of Manitoba Pen Research Collaboration

NEW YORK, Feb. 6 - Canadian proteomics company Miraculins has signed a research agreement with the University of Manitoba to use the school's time-of-flight mass-spectrometry technology, the company said recently.

 

The technology, Qstar, was developed by UM researchers Kenneth Standing and Werner Ens, with help from MDS-Sciex's quadrupole technology.

 

No further information was provided.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.